Active, not recruitingPHASE1, PHASE2NCT05975021
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Studying Cardiogenic shock
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Windtree Therapeutics
- Principal Investigator
- Steven G Simonson, MDWindtree Therapeutics, Inc.
- Intervention
- Istaroxime(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2024 – 2026
Study locations (15)
- Tufts Medical Center, Boston, Massachusetts, United States
- Oregon Health and Sciences University, Portland, Oregon, United States
- Sanatorio Güemes, Capital Federal, Buenos Aires, Argentina
- Sanatorio De la Trinidad Palermo, Capital Federal, Buenos Aires, Argentina
- Instituto Cardiovascular de Rosario, Rosario, Sante Fe, Argentina
- Hospital Privado de Rosario, Rosario, Sante Fe, Argentina
- Kaplan Medical Center, Rehovot, Israel
- Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
- ASST degli Spedali Civili di Brescia, Brescia, Italy
- IRCCS San Raffaele Scientific Institute, Milan, Italy
- University of Turin, Città della Salute e della Scienza, Turin, Italy
- Uniwersytecki Szpital Kliniczny w Białymstoku, Bialystok, Poland
- Uniwersytecki Szpital Kliniczny w Opolu, Opole, Poland
- Uniwersytecki Szpital Kliniczny, Instytut Chorob Serca, Wroclaw, Poland
- 4 Wojskowy Szpital Kliniczny z Polikliniką SP ZOZ, Wroclaw, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05975021 on ClinicalTrials.govOther trials for Cardiogenic shock
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07527156Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureInstitute for Clinical and Experimental Medicine
- RECRUITINGNANCT07345559Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic ShockCMC Ambroise Paré
- RECRUITINGNANCT07374289On Scene ECPR in OstravaUniversity Hospital Ostrava
- RECRUITINGNCT07402018Intra-aortic Balloon Counterpulsation (IABC) ComplianceThomas Jefferson University
- RECRUITINGNCT07309029Pre-Emptive LAVA-ECMO for Complex High-Risk TAVRAtlantic Health System
- RECRUITINGNANCT07293923Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockMagenta Medical Ltd.
- RECRUITINGNCT07354568Prognosis of Patients With Mixed Cardiogenic-Vasoplegic ShockCentre Hospitalier Universitaire, Amiens
- RECRUITINGNCT06964685Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockAbiomed Inc.